Cedar Hill Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-14,018
| Closed | -$1.33M | – | 109 |
|
|
2018
Q3 | $1.33M | Sell |
14,018
-4,570
| -25% | -$432K | 0.3% | 60 |
|
|
2018
Q2 | $1.72M | Buy |
18,588
+196
| +1% | +$18.2K | 0.36% | 57 |
|
|
2018
Q1 | $1.74M | Sell |
18,392
-42
| -0.2% | -$3.98K | 0.35% | 58 |
|
|
2017
Q4 | $1.78M | Buy |
18,434
+953
| +5% | +$92.2K | 0.31% | 62 |
|
|
2017
Q3 | $1.55M | Buy |
17,481
+4,608
| +36% | +$409K | 0.27% | 64 |
|
|
2017
Q2 | $933K | Hold |
12,873
| – | – | 0.19% | 61 |
|
|
2017
Q1 | $839K | Sell |
12,873
-274
| -2% | -$17.9K | 0.17% | 58 |
|
|
2016
Q4 | $823K | Hold |
13,147
| – | – | 0.14% | 55 |
|
|
2016
Q3 | $829K | Hold |
13,147
| – | – | 0.14% | 56 |
|
|
2016
Q2 | $814K | Hold |
13,147
| – | – | 0.14% | 58 |
|
|
2016
Q1 | $751K | Hold |
13,147
| – | – | 0.13% | 59 |
|
|
2015
Q4 | $779K | Hold |
13,147
| – | – | 0.14% | 59 |
|
|
2015
Q3 | $715K | Buy |
13,147
+100
| +0.8% | +$5.44K | 0.13% | 58 |
|
|
2015
Q2 | $877K | Sell |
13,047
-200
| -2% | -$13.4K | 0.14% | 61 |
|
|
2015
Q1 | $775K | Sell |
13,247
-820
| -6% | -$48K | 0.12% | 62 |
|
|
2014
Q4 | $921K | Buy |
14,067
+5,200
| +59% | +$340K | 0.15% | 64 |
|
|
2014
Q3 | $512K | Buy |
8,867
+174
| +2% | +$10K | 0.08% | 69 |
|
|
2014
Q2 | $491K | Buy |
8,693
+360
| +4% | +$20.3K | 0.08% | 67 |
|
|
2014
Q1 | $428K | Sell |
8,333
-650
| -7% | -$33.4K | 0.07% | 67 |
|
|
2013
Q4 | $474K | Hold |
8,983
| – | – | 0.08% | 66 |
|
|
2013
Q3 | $402K | Sell |
8,983
-110
| -1% | -$4.92K | 0.08% | 66 |
|
|
2013
Q2 | $376K | Buy |
+9,093
| New | +$376K | 0.07% | 69 |
|